Jennifer Bethell, M. Puts, S. Sattar, M. Andrew, Andrew S. Choate, Barry Clarke, K. Cowan, C. DeAngelis, J. Elliott, M. Fitch, Chris Frank, Kathryn Hominick, M. Keatings, J. Mcelhaney, S. McKay, E. Pitters, J. Ploeg, S. Sidani, K. McGilton
Background Patient engagement in research priority-setting is intended to democratize research and increase impact. The objectives of the Canadian Frailty Priority Setting Partnership (PSP) were to engage people with lived or clinical experience of frailty, and produce a list of research priorities related to care, support, and treatment of older adults living with frailty. Methods The Canadian Frailty PSP was supported by the Canadian Frailty Network, coordinated by researchers in Toronto, Ontario and followed the methods of the James Lind Alliance, which included establishing a Steering Group, inviting partner organizations, gathering questions related to care, support and treatment of older adults living with frailty, processing the data and prioritizing the questions. Results In the initial survey, 799 submissions were provided by 389 individuals and groups. The 647 questions that were within scope were categorized, merged, and summarized, then checked against research evidence, creating a list of 41 unanswered questions. Prioritization took place in two stages: first, 146 individuals and groups participated in survey and their responses short-listed 22 questions; and second, an in-person workshop was held on September 26, 2017 in Toronto, Ontario where these 22 questions were discussed and ranked. Conclusion Researchers and research funders can use these results to inform their agendas for research on frailty. Strategies are needed for involving those with lived experience of frailty in research.
{"title":"The Canadian Frailty Priority Setting Partnership: Research Priorities for Older Adults Living with Frailty","authors":"Jennifer Bethell, M. Puts, S. Sattar, M. Andrew, Andrew S. Choate, Barry Clarke, K. Cowan, C. DeAngelis, J. Elliott, M. Fitch, Chris Frank, Kathryn Hominick, M. Keatings, J. Mcelhaney, S. McKay, E. Pitters, J. Ploeg, S. Sidani, K. McGilton","doi":"10.5770/CGJ.22.336","DOIUrl":"https://doi.org/10.5770/CGJ.22.336","url":null,"abstract":"Background Patient engagement in research priority-setting is intended to democratize research and increase impact. The objectives of the Canadian Frailty Priority Setting Partnership (PSP) were to engage people with lived or clinical experience of frailty, and produce a list of research priorities related to care, support, and treatment of older adults living with frailty. Methods The Canadian Frailty PSP was supported by the Canadian Frailty Network, coordinated by researchers in Toronto, Ontario and followed the methods of the James Lind Alliance, which included establishing a Steering Group, inviting partner organizations, gathering questions related to care, support and treatment of older adults living with frailty, processing the data and prioritizing the questions. Results In the initial survey, 799 submissions were provided by 389 individuals and groups. The 647 questions that were within scope were categorized, merged, and summarized, then checked against research evidence, creating a list of 41 unanswered questions. Prioritization took place in two stages: first, 146 individuals and groups participated in survey and their responses short-listed 22 questions; and second, an in-person workshop was held on September 26, 2017 in Toronto, Ontario where these 22 questions were discussed and ranked. Conclusion Researchers and research funders can use these results to inform their agendas for research on frailty. Strategies are needed for involving those with lived experience of frailty in research.","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"22 1","pages":"23 - 33"},"PeriodicalIF":3.9,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41602927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Banihashemi, Shraddha Sapkota, S. Bronskill, D. Stuss, S. Black, Sayeh Bayat, G. Naglie, M. Rapoport, B. Ye, E. Stasiulis, Alex Mihailidis, Selena P. Maxwell, M. Cash, S. Darvesh, M. Teper, C. Hudon, I. Vedel, Xin Qiang Yang, V. Khanassov, E. Guseva, O. Lungu, I. Vedel, Sondra Goldman, M. Wilchesky, Angela Tam, C. Dansereau, Yasser Itturia-Medina, S. Urchs, P. Orban, J. Breitner, Pierre Bellec, Yassine Benhajali, Helen Spiers, A. Badhwar, S. Urchs, L. Trouille, Pierre Bellec, L. Wallace, O. Theou, Judith Godin, K. Rockwood, M. Andrew, D. Starblanket, C. Bourassa, C. Godard-Sebillotte, N. Sourial, L. Rochette, M. Hardouin, É. Pelletier, E. Strumpf, M. Ruthirakuhan, N. Herrmann, A. Andreazza, D. Gallagher, N. Verhoeff, S. Black, K. Lanctôt, Shanna C. Trenaman, M. Andrew, K. Goralski, Allen McLean, D. Morgan, J. Kosteniuk, M. O'connell, Melanie Bayly, A. Chow, Valerie Elliot, N. Osgood, A. Badhwar, Yannik Collin-Verreault, P. Orban, I. Chouinard, J. Vogel, Olivier Potvin, S. Duchesne, Pierre Bellec, S. Mi
-
-
{"title":"2018 Canadian Consortium on Neurodegeneration in Aging (CCNA) Science Day Abstracts (Montréal, Québec - October 1–2, 2018)","authors":"M. Banihashemi, Shraddha Sapkota, S. Bronskill, D. Stuss, S. Black, Sayeh Bayat, G. Naglie, M. Rapoport, B. Ye, E. Stasiulis, Alex Mihailidis, Selena P. Maxwell, M. Cash, S. Darvesh, M. Teper, C. Hudon, I. Vedel, Xin Qiang Yang, V. Khanassov, E. Guseva, O. Lungu, I. Vedel, Sondra Goldman, M. Wilchesky, Angela Tam, C. Dansereau, Yasser Itturia-Medina, S. Urchs, P. Orban, J. Breitner, Pierre Bellec, Yassine Benhajali, Helen Spiers, A. Badhwar, S. Urchs, L. Trouille, Pierre Bellec, L. Wallace, O. Theou, Judith Godin, K. Rockwood, M. Andrew, D. Starblanket, C. Bourassa, C. Godard-Sebillotte, N. Sourial, L. Rochette, M. Hardouin, É. Pelletier, E. Strumpf, M. Ruthirakuhan, N. Herrmann, A. Andreazza, D. Gallagher, N. Verhoeff, S. Black, K. Lanctôt, Shanna C. Trenaman, M. Andrew, K. Goralski, Allen McLean, D. Morgan, J. Kosteniuk, M. O'connell, Melanie Bayly, A. Chow, Valerie Elliot, N. Osgood, A. Badhwar, Yannik Collin-Verreault, P. Orban, I. Chouinard, J. Vogel, Olivier Potvin, S. Duchesne, Pierre Bellec, S. Mi","doi":"10.5770/cgj.22.358","DOIUrl":"https://doi.org/10.5770/cgj.22.358","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"22 1","pages":"34 - 48"},"PeriodicalIF":3.9,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47111707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Drummond, L. Mccleary, L. Garcia, K. McGilton, F. Molnar, W. Dalziel, T. J. Xu, D. Turner, J. Triscott, E. Freiheit
Background The trajectory of dementia through time is characterized by common transitions which are difficult for persons with dementia (PWDs) and their families and friends. Our study sought to identify determinants for the quality of transition outcomes. Method A 24-month, prospective, longitudinal design identified specific transitions as they occurred in 108 person-with-dementia/caregiver dyads, and assessed the perceived transition quality from the perspective of the caregiver and what we denote as the ‘summative’ transition quality outcome variable (as explained in the Data Processing section under Methods). Results Among caregivers and during the authors’ deliberations of the summative transition quality outcomes, good transition quality was associated with the PWD’s baseline Disability Assessment for Dementia (OR 1.04, 95% CI 1.02–1.06 per increase in percent score based on summative assessments), and with the PWD’s higher baseline quality of life scores (OR 1.11, 95% CI 1.05–1.18 per increase in unit of score in QOL-AD based on summative assessments). Caregiver-perceived better outcome quality was associated with lower caregiver burden, (OR 0.97, 95% CI 0.95–0.99 per unit CBI score increase). Conclusion Identifying determinants of successful transitions is feasible and may be translated into practical guidance for use in clinical encounters. Those with worse prior quality of life or worse performance in activities of daily living appear to require specific support during transitions, as do those whose caregivers report higher levels of burden.
随着时间的推移，痴呆症的发展轨迹具有共同的过渡特征，这对痴呆症患者及其家人和朋友来说是困难的。我们的研究试图确定过渡结果质量的决定因素。方法一项为期24个月的前瞻性纵向设计确定了108名痴呆症患者/护理人员的特定过渡，并从护理人员的角度评估了感知的过渡质量，以及我们所说的“总结性”过渡质量结果变量(如方法下的数据处理部分所述)。结果在护理人员中，在作者对总结性过渡质量结果的审议过程中，良好的过渡质量与PWD的痴呆基线残疾评估(基于总结性评估的百分比分数每增加1.04,95% CI 1.02-1.06)和PWD较高的基线生活质量评分(基于总结性评估的QOL-AD评分单位每增加1.11,95% CI 1.05-1.18)相关。照顾者感知更好的结局质量与照顾者负担降低相关(OR 0.97, 95% CI 0.95-0.99 /单位CBI评分增加)。结论确定成功转化的决定因素是可行的，并可转化为临床遭遇使用的实用指导。那些先前生活质量较差或日常生活活动表现较差的人在过渡期间似乎需要特殊的支持，那些照顾者报告负担较高的人也是如此。
{"title":"Assessing Determinants of Perceived Quality in Transitions for People with Dementia: a Prospective Observational Study","authors":"N. Drummond, L. Mccleary, L. Garcia, K. McGilton, F. Molnar, W. Dalziel, T. J. Xu, D. Turner, J. Triscott, E. Freiheit","doi":"10.5770/cgj.22.332","DOIUrl":"https://doi.org/10.5770/cgj.22.332","url":null,"abstract":"Background The trajectory of dementia through time is characterized by common transitions which are difficult for persons with dementia (PWDs) and their families and friends. Our study sought to identify determinants for the quality of transition outcomes. Method A 24-month, prospective, longitudinal design identified specific transitions as they occurred in 108 person-with-dementia/caregiver dyads, and assessed the perceived transition quality from the perspective of the caregiver and what we denote as the ‘summative’ transition quality outcome variable (as explained in the Data Processing section under Methods). Results Among caregivers and during the authors’ deliberations of the summative transition quality outcomes, good transition quality was associated with the PWD’s baseline Disability Assessment for Dementia (OR 1.04, 95% CI 1.02–1.06 per increase in percent score based on summative assessments), and with the PWD’s higher baseline quality of life scores (OR 1.11, 95% CI 1.05–1.18 per increase in unit of score in QOL-AD based on summative assessments). Caregiver-perceived better outcome quality was associated with lower caregiver burden, (OR 0.97, 95% CI 0.95–0.99 per unit CBI score increase). Conclusion Identifying determinants of successful transitions is feasible and may be translated into practical guidance for use in clinical encounters. Those with worse prior quality of life or worse performance in activities of daily living appear to require specific support during transitions, as do those whose caregivers report higher levels of burden.","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"22 1","pages":"13 - 22"},"PeriodicalIF":3.9,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42509986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background Post-operative delirium (POD) is associated with higher rates of functional decline and death. Ondansetron is a serotonin antagonist which could represent a therapeutic or preventive option in POD. Methods A systematic review of MEDLINE, EMBASE, CENTRAL, and PsychINFO was performed. Three randomized controlled trials (RCTs) met inclusion criteria (intervention of ondansetron compared to a control group). Results Two RCTs examined ondansetron for the treatment of POD in patients after cardiac or post-trauma surgery in the ICU. Studies assessed either a one-time dose or doses for 3 days of ondansetron or haloperidol IV. They suggested similar reductions in average delirium scores and rates in both interventions, although one study suggested ondansetron to be associated with higher rates of rescue haloperidol use. One RCT examined prophylactic ondansetron versus placebo IV, for five days postoperatively, to prevent POD in orthopedic patients. There were significantly fewer delirious patients in the ondansetron group. In general, studies had major methodological limitations and were very heterogenous in study tools, interventions used, and populations studied. Conclusions Ondansetron may be an effective agent for the prevention or treatment of POD, but studies are few and of poor quality, thus making the conclusions tenuous. Further large RCTs are needed.
{"title":"Efficacy of Ondansetron in the Prevention or Treatment of Post-operative Delirium—a Systematic Review","authors":"Nihal Haque, R. Naqvi, M. Dasgupta","doi":"10.5770/cgj.22.266","DOIUrl":"https://doi.org/10.5770/cgj.22.266","url":null,"abstract":"Background Post-operative delirium (POD) is associated with higher rates of functional decline and death. Ondansetron is a serotonin antagonist which could represent a therapeutic or preventive option in POD. Methods A systematic review of MEDLINE, EMBASE, CENTRAL, and PsychINFO was performed. Three randomized controlled trials (RCTs) met inclusion criteria (intervention of ondansetron compared to a control group). Results Two RCTs examined ondansetron for the treatment of POD in patients after cardiac or post-trauma surgery in the ICU. Studies assessed either a one-time dose or doses for 3 days of ondansetron or haloperidol IV. They suggested similar reductions in average delirium scores and rates in both interventions, although one study suggested ondansetron to be associated with higher rates of rescue haloperidol use. One RCT examined prophylactic ondansetron versus placebo IV, for five days postoperatively, to prevent POD in orthopedic patients. There were significantly fewer delirious patients in the ondansetron group. In general, studies had major methodological limitations and were very heterogenous in study tools, interventions used, and populations studied. Conclusions Ondansetron may be an effective agent for the prevention or treatment of POD, but studies are few and of poor quality, thus making the conclusions tenuous. Further large RCTs are needed.","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"22 1","pages":"1 - 6"},"PeriodicalIF":3.9,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44985453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CAGP-CCSMH Annual Scientific Meeting Canadian Academy of Geriatric Psychiatry and Canadian Coalition for Seniors’ Mental Health","authors":"V. Authors","doi":"10.5770/cgj.21.356","DOIUrl":"https://doi.org/10.5770/cgj.21.356","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"21 1","pages":"320 - 342"},"PeriodicalIF":3.9,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44013728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CGS 38th Annual Scientific Meeting Advances in Care: From the Individual to the Technology","authors":"V. Authors","doi":"10.5770/cgj.21.334","DOIUrl":"https://doi.org/10.5770/cgj.21.334","url":null,"abstract":"<jats:p>-</jats:p>","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"1 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2018-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48817833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The world is undergoing a major demographic shift as the population ages exponentially. A transformational change is required to optimize brain health, mental wellness and aging for all. Positive psychiatry aims to broaden the scope of traditional psychiatric practice by looking beyond symptom improvement into the realm of relapse prevention and resilience. The Fountain of Health (FoH) Initiative for optimal aging is a unique Canadian strategy that demonstrates positive psychiatry in action.
{"title":"Canadian Academy of Geriatric Psychiatry (CAGP) 2017 Annual Scientific Meeting Book of Abstracts","authors":"Y. Iwata, Julia Kim, M. Chakravarty, Philip","doi":"10.5770/cgj.21.320","DOIUrl":"https://doi.org/10.5770/cgj.21.320","url":null,"abstract":"Background: The world is undergoing a major demographic shift as the population ages exponentially. A transformational change is required to optimize brain health, mental wellness and aging for all. Positive psychiatry aims to broaden the scope of traditional psychiatric practice by looking beyond symptom improvement into the realm of relapse prevention and resilience. The Fountain of Health (FoH) Initiative for optimal aging is a unique Canadian strategy that demonstrates positive psychiatry in action.","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"21 1","pages":"32 - 70"},"PeriodicalIF":3.9,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46954923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Warrick, D. Seitz, J. Prorok, D. Shawcross, T. Mahootchi, A. Esensoy
Background/Objectives: Comprehensive mapping of evidence-based interventions for the health and supportive service needs of individuals with dementia is an important first step in capacity planning. A scoping review was undertaken to generate potential candidates for simulation and scenario modelling. We achieved these aims by identifying the most promising interventions for improving outcomes for persons living with dementia, care partners and the health system.
{"title":"Poster Presentations at the 9th Canadian Conference on Dementia (CCD) Toronto, November 2017","authors":"N. Warrick, D. Seitz, J. Prorok, D. Shawcross, T. Mahootchi, A. Esensoy","doi":"10.5770/cgj.21.321","DOIUrl":"https://doi.org/10.5770/cgj.21.321","url":null,"abstract":"Background/Objectives: Comprehensive mapping of evidence-based interventions for the health and supportive service needs of individuals with dementia is an important first step in capacity planning. A scoping review was undertaken to generate potential candidates for simulation and scenario modelling. We achieved these aims by identifying the most promising interventions for improving outcomes for persons living with dementia, care partners and the health system.","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"21 1","pages":"71 - 133"},"PeriodicalIF":3.9,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48921825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Oral Abstract Presentations at the 9th Canadian Conference on Dementia (CCD) Toronto, November 2017","authors":"Conference Services","doi":"10.5770/cgj.21.322","DOIUrl":"https://doi.org/10.5770/cgj.21.322","url":null,"abstract":"","PeriodicalId":56182,"journal":{"name":"Canadian Geriatrics Journal","volume":"21 1","pages":"134 - 137"},"PeriodicalIF":3.9,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44960660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：